Vamorolone | CAS 13209-41-1 - Request Quote
Vamorolone
| SZ CAT No: | SZ-V054001 |
| CAS No | 13209-41-1 |
| Mol.F. | C22H28O4 |
| Mol.Wt. | 356.5 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Vamorolone is chemically (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one. It is also known as Dexamethasone EP Impurity E. Vamorolone is supplied with detailed characterization data compliant with regulatory guideline. Vamorolone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vamorolone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 13209-41-1
Purchase 13209-41-1
Order 13209-41-1
Enquire 13209-41-1
price of 13209-41-1
13209-41-1 Supplier
13209-41-1 Manufacturer
13209-41-1 Exporter
buy high quality Vamorolone
Purchase Vamorolone
Vamorolone suppliers
Vamorolone manufacturers
Vamorolone price
Order Vamorolone
Enquire Vamorolone
Vamorolone cost
Vamorolone Supplier
Vamorolone Distributor
Vamorolone for Method Validation
Vamorolone Reference Standard
Vamorolone for ANDA Filing
Vamorolone for Forced Degradation Studies
Vamorolone Identification Standards
Vamorolone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


